Digipath
Home > Boards > US Listed > Biotechs >

La Jolla Pharmaceutical Co. (LJPC)

LJPC RSS Feed
Add LJPC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/20/2019 5:24:50 AM - Followers: 120 - Board type: Free - Posts Today: 0

http://www.ljpc.com/

http://finance.yahoo.com/q/h?s=LJPC

La Jolla Pharmaceutical Company, a biopharmaceutical company, engages in the research and development of pharmaceutical products in the United States. Its principal product in development is Riquent, which is designed to treat lupus renal disease by preventing or delaying renal flares. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. Riquent is in Phase III clinical trial. The company also develops small molecules for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders. La Jolla Pharmaceutical Company was founded in 1989 and is based in San Diego, California.  

Riquent

Riquent (abetimus sodium)

Riquent (abetimus sodium) is a synthetic oligonucleotide conjugate composed of 4 identical strands of dsDNA (20BP in length) that are linked through a triethyleneglycol-based platform. It binds anti-dsDNA Ab and the complex is cleared via the immune system, thus ridding the body of one of the primary pathogenic antibody associated with lupus.

Lupus nephritis is a serious and potentially fatal orphan disease treated primarily by nephrologists and rheumatologists. Currently, there are no products specifically approved to treat lupus renal disease.

La Jolla Pharmaceutical is investigating Riquent for the treatment of lupus renal disease by preventing or delaying renal flares, a leading cause of sickness and death in lupus patients, and improving proteinuria. Proteinuria is an indicator of abnormal renal function. Riquent has been well tolerated in all 14 clinical trials, with no overall difference in the adverse event profiles for Riquent-treated patients compared with placebo-treated patients. Riquent specifically reduces circulating levels of anti-dsDNA antibodies and is also designed to specifically suppress the B cells that make these antibodies. Decreases in these antibodies are believed to be associated with a decreased risk of renal flare. Although clinical benefit has not yet been proven, Riquent treatment has significantly reduced these antibody levels in all clinical trials in which they were measured.



 

CHARTS

 

 

3 Month Chart

Digipath
LJPC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3026   Tang seems to be right most of the time Golden_Cross 01/20/19 05:24:50 AM
#3025   Large Biotech Stock Holder Slashes Stake, but Insiders Golden_Cross 01/20/19 05:13:19 AM
#3024   Insider trades... 3 separate Buys: Golden_Cross 01/20/19 05:02:52 AM
#3023   Looks like a good bottom play here imo Golden_Cross 01/20/19 05:00:16 AM
#3022   Wednesday’s presentation at J.P. Morgan Healthcare Conference probably StockLearner2011 01/07/19 04:19:11 PM
#3021   Even a buyout will not help this stock. StockLearner2011 01/07/19 04:13:57 PM
#3020   News is not bad, but shorts are in StockLearner2011 01/07/19 04:10:53 PM
#3019   Very bad day in LJPC land today. Is mauiguy2 01/07/19 11:23:13 AM
#3018   Great job killing the longs!?? StockLearner2011 12/21/18 10:11:39 AM
#3017   Great job killing the Kong’s! ?? StockLearner2011 12/21/18 10:11:05 AM
#3016   Let’s kill the shorts ?????? StockLearner2011 12/07/18 11:45:34 AM
#3015   https://www.mdmag.com/medical-news/ashish-khanna-md-checking-in-on-angiotensin-2 StockLearner2011 12/07/18 06:55:44 AM
#3014   This stock will be a gem in 2 StockLearner2011 11/29/18 02:00:02 PM
#3013   No volume, sending shorts to hell is the StockLearner2011 11/27/18 03:08:04 PM
#3012   It will be interesting when the product gets StockLearner2011 11/19/18 04:29:21 PM
#3011   When are you sending shorts to HELL? ???????????? StockLearner2011 11/19/18 10:09:01 AM
#3010   I smell buy out talks.?? StockLearner2011 11/14/18 01:26:59 PM
#3009   Blockbuster earning! Bingo!???????? StockLearner2011 10/24/18 10:35:58 AM
#3008   Here comes my death penalty!!! I’ll be happy StockLearner2011 10/22/18 01:28:08 PM
#3007   Will the earning be the blowout of shorts StockLearner2011 10/19/18 01:00:44 PM
#3006   Another bloody day and many more bloody days ahead!!! StockLearner2011 10/15/18 10:19:29 AM
#3005   If it’s a buyout, which company will be StockLearner2011 10/10/18 06:05:00 PM
#3004   Let’s announce buyout news soon?? StockLearner2011 10/08/18 04:57:32 PM
#3003   Will LJPC like JUNO? JUNO was down for StockLearner2011 10/04/18 03:17:51 PM
#3002   Let’s go down to $15 please StockLearner2011 09/21/18 10:19:25 AM
#3001   No volume StockLearner2011 08/30/18 04:25:33 PM
#3000   Sold @ $22.40 near the EOD. Took profits chmcnfunds 08/16/18 03:37:48 PM
#2999   In @ $21.30. 52 week low. Looking for chmcnfunds 08/15/18 11:16:08 AM
#2998   Ouch Elijah875 08/10/18 12:24:32 PM
#2997   A very rough day for LJPC today......down 25% mauiguy2 08/09/18 05:36:14 PM
#2996   Good CC this morning looks like the company Pineapple1 12/22/17 11:40:14 PM
#2995   Good to see that Lajolla is doing well, jones99 12/22/17 06:44:18 AM
#2994   Ah that's what happened thanks Pineapple1 12/09/17 03:41:51 PM
#2993   JPM downgrades LJPC, new PT is $20 north40000 12/08/17 09:31:19 AM
#2992   https://seekingalpha.com/article/4075441-full-phase-3-la-jolla-pharmaceutical-da Inoviorulez 05/22/17 05:38:34 PM
#2991   Karm is a B Adam, hope you were Pineapple1 05/18/17 01:28:50 PM
#2990   Adam Feuerstein: $LJPC halted stock for this? Ridiculous. davidsson10 05/18/17 12:48:56 PM
#2989   La Jolla Pharmaceutical Company Announces Positive Top-Line Results starbuxsux 03/01/17 10:02:49 AM
#2988   $37's hit grat alert S1A1 [SMART MONEY] 02/27/17 01:52:20 PM
#2987   36s up ! Epic run stock1ace1 02/27/17 01:01:07 PM
#2986   Breaking HOD Know ;) stock1ace1 02/27/17 11:10:31 AM
#2985   WOW HIT $30'S IN PM ON NEWS [SMART MONEY] 02/27/17 09:07:38 AM
#2984   fast and steady profit scan LJPC bullish 23.79 stocktrademan 09/30/16 04:46:37 PM
#2983   LJPC bullish 16.32 stocktrademan 09/02/16 04:39:24 PM
#2982   Could be...but just as quickly could rebound as much starbuxsux 01/06/16 10:21:50 AM
#2981   Charts suggest La Jolla Pharmaceuticals will fall 50% http://www.thewallstreetfo longtermgems 01/06/16 09:29:48 AM
#2980   Perceptive Advisors Llc Increased La Jolla Pharmaceutical Co starbuxsux 12/02/15 03:54:33 PM
#2979   Stock offering for LJPC. Although the PPS is mauiguy2 09/10/15 09:37:29 AM
#2978   Great action here!!! ridinbulls 09/08/15 03:12:03 PM
#2977   WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!! starbuxsux 09/08/15 01:17:20 PM
PostSubject